HR 2125
117th Congress
House
Health
Cardiovascular and respiratory health
Child health
Drug therapy
Drug, alcohol, tobacco use
Emergency medical services and trauma care
Health care costs and insurance
Health care coverage and access
Health promotion and preventive care
Infectious and parasitic diseases
Medicaid
Medical tests and diagnostic methods
Poverty and welfare assistance
Prescription drugs
State and local government operations
U.S. territories and protectorates
Quit Because of COVID–19 Act
Introduced: March 23, 2021
Introduced by:
Blunt Rochester, Lisa
Democratic
· Delaware
See on congress.gov
Everywhere this bill has been
3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Mar 24, 2021
Referred to the Subcommittee on Health.
Mar 23, 2021
Referred to the House Committee on Energy and Commerce.
Mar 23, 2021
Introduced in House
Plain-English summary
Quit Because of COVID-19 Act
This bill provides for Medicaid and Children's Health Insurance Program (CHIP) coverage of certain tobacco cessation services.
Specifically, the bill provides for coverage, without cost-sharing, of diagnostic, therapy, and counseling services and pharmacotherapy, including prescription and nonprescription tobacco cessation agents, that are provided under medical supervision and in accordance with specified guidelines. It also applies a 100% Federal Medical Assistance Percentage (i.e., federal matching rate) for such items and services during the public health emergency relating to COVID-19 and for two years after the emergency period ends.
What's happening now
Referred to the Subcommittee on Health.
Committees of jurisdiction
2